Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.600.530.420.490.32

What is the latest Fixed Capital/Sales ratio of BLISS GVS PHARMA ?

The latest Fixed Capital/Sales ratio of BLISS GVS PHARMA is 0.60 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.60
Mar20230.53
Mar20220.42
Mar20210.49
Mar20200.32

How is Fixed Capital/Sales of BLISS GVS PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.6
13.21
Mar2023 0.53
26.19
Mar2022 0.42
-14.29
Mar2021 0.49
53.13
Mar2020 0.32 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Fixed Capital/Sales ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,254.3 Cr -5.8% -1.7% 5.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,126.0 Cr 1.4% 4.1% 18.7% Stock Analytics
DIVIS LABORATORIES ₹161,568.0 Cr -2.1% 4.2% 59.1% Stock Analytics
CIPLA ₹125,156.0 Cr -0.1% 5% 9.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,176.0 Cr -0.3% 3% 23.4% Stock Analytics
DR REDDYS LABORATORIES ₹98,716.1 Cr -1.5% 1.7% -5.4% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-5.8%

-1.7%

5.1%

SENSEX

0.2%

2.9%

8.7%


You may also like the below Video Courses